The Shuman Law Firm Investigates Gentiva Health Services, Inc.

The Shuman Law Firm Investigates Gentiva Health Services, Inc.

The Shuman Law Firm announced today that it is investigating potential claims against certain officers and directors of Gentiva Health Services, Inc. (“Gentiva” or the “Company”) (NASDAQ: GTIV). Gentiva provides home health services and hospice care.

The Shuman Law Firm’s investigation focuses on allegations that the Company was improperly increasing the number of in-home therapy visits to patients for the purpose of triggering higher reimbursement rates under the Medicare system.

On May 13, 2010, The Wall Street Journal reported that Gentiva was the target of an investigation by the U.S. Senate Finance Committee to determine whether companies that provide Medicare-reimbursed in-home therapy visits “deliberately boosted the number of home therapy visits to trigger higher Medicare reimbursements.” The Senate Finance Committee requested information on Gentiva's home therapy visits from 2006 to 2009. Following the commencement of the Senate Finance Committee’s investigation, Gentiva common stock has declined, falling from a high of $30.50 per share in April of 2010 to a recent closing price of $6.01 per share on September 27, 2011.

If you currently own shares of Gentiva common stock and are interested in discussing your rights as a shareholder, or have information relating to this investigation, please contact Kip B. Shuman or Rusty E. Glenn toll-free at (866) 974-8626 or email Mr. Shuman at kip@shumanlafirm.com or email Mr. Glenn at rusty@shumanlawfirm.com.

The Shuman Law Firm represents investors throughout the nation, concentrating its practice in securities class actions and shareholder derivative actions.

The Shuman Law Firm
Kip B. Shuman, Esq., 866-974-8626
kip@shumanlawfirm.com
or
Rusty E. Glenn, Esq., 866-974-8626
rusty@shumanlawfirm.com
Fax: 303-484-4886
www.shumanlawfirm.com